Versant Venture Capital VI L.P. 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-08 5:35 pm Unchanged |
2023-12-31 | 13G | Century Therapeutics, Inc. IPSC |
Versant Venture Capital VI L.P. | 11,452,014 19.100% |
0 (Unchanged) |
Filing |
| 2023-02-09 4:19 pm Sale |
2022-12-31 | 13G | Century Therapeutics, Inc. IPSC |
Versant Venture Capital VI L.P. | 11,452,014 19.400% |
-914,800 (-7.40%) |
Filing |
| 2022-02-10 8:39 pm Purchase |
2021-12-31 | 13G | Century Therapeutics, Inc. IPSC |
Versant Venture Capital VI L.P. | 12,366,814 22.600% |
12,366,814 (New Position) |
Filing |